CLX vs HSIC · P/E 15, rev $7.10B vs P/E 24, rev $6.83B
The Clorox Company (CLX) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the CLX and HSIC stock pages for the full models.
Not investment advice.